Discussion Brief
As stated by the World Health Organization, “lack of diagnostic capacity is a crucial barrier preventing an effective response to the challenges of TB-HIV and drug-resistant TB, with less than 5% of the estimated burden of MDR-TB patients currently being detected.”
In this discussion, members exchange recommendations and key references that inform the minimal volume of specimens for lab smear, culture and drug susceptibility testing needed in order to maintain lab proficiency.
Sign in to read complete brief
Related content from other Communities
